STAT3 and glioblastoma: Because the group 2 was characterized by tumor-FKBP51s expression significantly higher than that of group 1 (Fig. 1B, bottom), we investigated whether FKBP51s regulated STAT3 activation, a transcription factor that sustains GBM-induced immunosuppression (33).